Does NILOTINIB Cause Malignant neoplasm progression? 581 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 581 reports of Malignant neoplasm progression have been filed in association with NILOTINIB (nilotinib). This represents 2.5% of all adverse event reports for NILOTINIB.
581
Reports of Malignant neoplasm progression with NILOTINIB
2.5%
of all NILOTINIB reports
237
Deaths
155
Hospitalizations
How Dangerous Is Malignant neoplasm progression From NILOTINIB?
Of the 581 reports, 237 (40.8%) resulted in death, 155 (26.7%) required hospitalization, and 34 (5.9%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NILOTINIB. However, 581 reports have been filed with the FAERS database.
What Other Side Effects Does NILOTINIB Cause?
Death (2,667)
Fatigue (1,679)
Rash (1,250)
Nausea (1,180)
Headache (1,177)
Pain (1,169)
Dyspnoea (1,070)
Diarrhoea (998)
Drug ineffective (992)
Malaise (961)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which NILOTINIB Alternatives Have Lower Malignant neoplasm progression Risk?
NILOTINIB vs NIMESULIDE
NILOTINIB vs NIMODIPINE
NILOTINIB vs NINTEDANIB
NILOTINIB vs NINTEDANIB ESYLATE
NILOTINIB vs NIRAPARIB